Literature DB >> 2961190

Effect of ipratropium bromide aerosol on respiratory function in patients under ventilator treatment.

T Wegener1, S Wretman, B Sandhagen, S O Nyström.   

Abstract

Twenty patients, 36-78 years old, with a history of chronic obstructive lung disease, and immediately after operation mostly for cardiac disease, were treated with ipratropium bromide (IB, 15 cases) or placebo (5 cases). A metered dose inhaler with a new adapter was used during postoperative ventilator treatment. In the IB group the heart rate did not change, but the inspiratory resistance decreased and the arterial oxygen tension increased. This is considered to indicate an effect not only on large but also on small airways, or an improvement of the ventilation/perfusion relationship. The investigation also demonstrated the practical usefulness of the new adapter.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2961190     DOI: 10.1111/j.1399-6576.1987.tb02638.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

Review 1.  Nebuliser therapy in the intensive care unit.

Authors:  M J O'Doherty; S H Thomas
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 2.  Aerosols for therapy and diagnosis.

Authors:  M J O'Doherty; R F Miller
Journal:  Eur J Nucl Med       Date:  1993-12

3.  Pulmonary deposition of a nebulised aerosol during mechanical ventilation.

Authors:  S H Thomas; M J O'Doherty; H M Fidler; C J Page; D F Treacher; T O Nunan
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.